# Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients.

> **NCT06951581** · NA · COMPLETED · sponsor: **University Hospital, Martin** · enrollment: 41 (actual)

## Conditions studied

- Metabolic Effects
- Immunosuppressive Agents
- Adverse Events
- Imunological Effects
- Inflamatory Markers
- Metabolomic Effects
- Renal Function

## Interventions

- **DIETARY_SUPPLEMENT:** Short Chain Fatty Acid
- **DIETARY_SUPPLEMENT:** Placebo Capsule(s)

## Key facts

- **NCT ID:** NCT06951581
- **Lead sponsor:** University Hospital, Martin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-15
- **Primary completion:** 2024-07-15
- **Final completion:** 2024-07-30
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06951581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06951581, "Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients.". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06951581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*